Form D · Biotechnology
Summation Bio, Inc.
Somerville, MA · CIK 0001920601
Offering snapshot reported Apr 5, 2022 · SEC filing
- Reported sold
- $24.5M Offering amount: $64.5M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 21, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2022 | Initial | $24,462,489 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-440343
Source: Form D, filed Apr 5, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Luc Dochez | Director |
| Reza Halse | Director |
| Adarsha Koirala | Director, Executive |
| Gerald Sewack | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
519 Somerville Ave, Num 326
Somerville, MA, 02143
Somerville, MA, 02143